OTTM: an automated classification tool for translational drug discovery from omics data
文献类型:期刊论文
作者 | Yang, Xiaobo2; Zhang, Bei3,4; Wang, Siqi1,5; Lu, Ye6,7; Chen, Kaixian2,3,4,6; Luo, Cheng4,6,8; Sun, Aihua9,10; Zhang, Hao8 |
刊名 | BRIEFINGS IN BIOINFORMATICS |
出版日期 | 2023-08-18 |
页码 | 12 |
ISSN号 | 1467-5463 |
关键词 | OTTM omics data translational drug discovery literature mining hepatocellular carcinoma |
DOI | 10.1093/bib/bbad301 |
通讯作者 | Luo, Cheng(cluo@simm.ac.cn) ; Sun, Aihua(sunah620@126.com) ; Zhang, Hao(hao_cadd@simm.ac.cn) |
英文摘要 | Omics data from clinical samples are the predominant source of target discovery and drug development. Typically, hundreds or thousands of differentially expressed genes or proteins can be identified from omics data. This scale of possibilities is overwhelming for target discovery and validation using biochemical or cellular experiments. Most of these proteins and genes have no corresponding drugs or even active compounds. Moreover, a proportion of them may have been previously reported as being relevant to the disease of interest. To facilitate translational drug discovery from omics data, we have developed a new classification tool named Omics and Text driven Translational Medicine (OTTM). This tool can markedly narrow the range of proteins or genes that merit further validation via drug availability assessment and literature mining. For the 4489 candidate proteins identified in our previous proteomics study, OTTM recommended 40 FDA-approved or clinical trial drugs. Of these, 15 are available commercially and were tested on hepatocellular carcinoma Hep-G2 cells. Two drugs-tafenoquine succinate (an FDA-approved antimalarial drug targeting CYC1) and branaplam (a Phase 3 clinical drug targeting SMN1 for the treatment of spinal muscular atrophy)-showed potent inhibitory activity against Hep-G2 cell viability, suggesting that CYC1 and SMN1 may be potential therapeutic target proteins for hepatocellular carcinoma. In summary, OTTM is an efficient classification tool that can accelerate the discovery of effective drugs and targets using thousands of candidate proteins identified from omics data. The online and local versions of OTTM are available at . |
WOS关键词 | TAFENOQUINE |
资助项目 | National Key Ramp;D Program of China[2020YFE0202200] ; National Key Ramp;D Program of China[2022YFC3400500] ; National Key Ramp;D Program of China[2021ZD0203900] ; National Natural Science Foundation of China[81903538] ; National Natural Science Foundation of China[81821005] ; National Natural Science Foundation of China[92253303] ; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences[2019-I2M-5-063] ; Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine[ZYYCXTD-D-202004] ; Lingang Laboratory[LG-QS-202204-07] ; High-level New Ramp;D Institute[2019B090904008] ; High-level Innovative Research Institute from the Department of Science and Technology of Guangdong Province[2021B0909050003] |
WOS研究方向 | Biochemistry & Molecular Biology ; Mathematical & Computational Biology |
语种 | 英语 |
出版者 | OXFORD UNIV PRESS |
WOS记录号 | WOS:001050594900001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/306947] |
专题 | 新药研究国家重点实验室 |
通讯作者 | Luo, Cheng; Sun, Aihua; Zhang, Hao |
作者单位 | 1.Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China 2.ShanghaiTech Univ, Sch Life Sci & Technol, 393 Huaxiazhong Rd, Shanghai 200031, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China 4.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 5.Natl Ctr Prot Sci Beijing, Beijing, Peoples R China 6.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China 7.Chinese Acad Sci, Shanghai Inst Materia Med, Chem Biol Res Ctr, Shanghai 201203, Peoples R China 8.Chinese Acad Sci, Shanghai Inst Mat Med, Chem Biol Res Ctr, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China 9.Beijing Inst Life, Beijing Proteome Res Ctr, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing, Peoples R China 10.Chinese Acad Med Sci, Res Unit Prote Driven Canc Precis Med, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Yang, Xiaobo,Zhang, Bei,Wang, Siqi,et al. OTTM: an automated classification tool for translational drug discovery from omics data[J]. BRIEFINGS IN BIOINFORMATICS,2023:12. |
APA | Yang, Xiaobo.,Zhang, Bei.,Wang, Siqi.,Lu, Ye.,Chen, Kaixian.,...&Zhang, Hao.(2023).OTTM: an automated classification tool for translational drug discovery from omics data.BRIEFINGS IN BIOINFORMATICS,12. |
MLA | Yang, Xiaobo,et al."OTTM: an automated classification tool for translational drug discovery from omics data".BRIEFINGS IN BIOINFORMATICS (2023):12. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。